SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'OGA'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A4L_A_DCFA353_1 (ADENOSINE DEAMINASE)	4bhi	GAMMA-BUTYROBETAINE DIOXYGENASE (Homo sapiens)	5 / 12	HIS A 202 ASP A 261 ALA A 193 HIS A 347 ASP A 204	ZN A 402 ( 3.3A) RUJ A 401 ( 4.7A) OGA A 400 (-3.1A) ZN A 402 ( 3.3A) ZN A 402 (-2.6A)	1.26A	1a4lA-4bhiA: undetectable	1a4lA-4bhiA: 22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A4L_C_DCFC1353_1 (ADENOSINE DEAMINASE)	4bhi	GAMMA-BUTYROBETAINE DIOXYGENASE (Homo sapiens)	5 / 12	HIS A 202 ASP A 261 ALA A 193 HIS A 347 ASP A 204	ZN A 402 ( 3.3A) RUJ A 401 ( 4.7A) OGA A 400 (-3.1A) ZN A 402 ( 3.3A) ZN A 402 (-2.6A)	1.25A	1a4lC-4bhiA: undetectable	1a4lC-4bhiA: 22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EI6_A_PPFA410_1 (PHOSPHONOACETATE HYDROLASE)	2rds	FE(II)/ALPHA-KETOGL UTARATE DEPENDENT HYDROXYLASE 1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE (Streptomyces avermitilis)	4 / 5	THR A 151 ASP A 139 HIS A 137 HIS A 226	OGA A 268 (-3.8A) FE A 1 ( 2.6A) FE A 1 (-3.4A) FE A 1 ( 3.4A)	1.16A	1ei6A-2rdsA: undetectable	1ei6A-2rdsA: 21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MEI_A_MOAA600_1 (INOSINE-5'-MONOPHOSP HATE DEHYDROGENASE)	5jz8	ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (Homo sapiens)	4 / 8	ASP A 721 SER A 722 SER A 563 ARG A 662	OGA A 802 ( 4.8A) None None None	0.95A	1meiA-5jz8A: undetectable	1meiA-5jz8A: 20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_D_BEZD507_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	4 / 7	ARG A 277 ALA A 279 ILE A 186 ILE A 95	OGA A 402 (-2.7A) OGA A 402 (-3.6A) ARG A 403 (-4.7A) None	0.79A	1oniD-5lunA: undetectable 1oniF-5lunA: undetectable	1oniD-5lunA: 17.01 1oniF-5lunA: 17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q23_A_FUAA702_1 (CHLORAMPHENICOL ACETYLTRANSFERASE)	3pua	PHD FINGER PROTEIN 2 (Homo sapiens)	5 / 12	THR A 325 TYR A 259 PHE A 268 SER A 244 ALA A 333	None OGA A 454 (-4.6A) None None EDO A 9 ( 3.9A)	1.29A	1q23A-3puaA: undetectable 1q23B-3puaA: undetectable	1q23A-3puaA: 18.25 1q23B-3puaA: 18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	2rds	1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE FE(II)/ALPHA-KETOGL UTARATE DEPENDENT HYDROXYLASE (Streptomyces avermitilis)	5 / 12	LEU A 218 HIS A 137 ASP A 139 SER A 172 PHE A 220	None FE A 1 (-3.4A) FE A 1 ( 2.6A) None OGA A 268 (-4.9A)	1.46A	1uobA-2rdsA: 9.9	1uobA-2rdsA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	4j25	PUTATIVE UNCHARACTERIZED PROTEIN (Pseudomonas putida)	5 / 12	HIS A 124 ASP A 126 HIS A 183 SER A 194 VAL A 139	MN A 401 ( 3.3A) MN A 401 ( 2.6A) MN A 401 ( 3.3A) OGA A 402 ( 3.7A) OGA A 402 ( 4.9A)	1.44A	1uobA-4j25A: 10.3	1uobA-4j25A: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	4j25	PUTATIVE UNCHARACTERIZED PROTEIN (Pseudomonas putida)	5 / 12	HIS A 124 ASP A 126 LEU A 154 HIS A 183 SER A 194	MN A 401 ( 3.3A) MN A 401 ( 2.6A) OGA A 402 (-3.7A) MN A 401 ( 3.3A) OGA A 402 ( 3.7A)	0.61A	1uobA-4j25A: 10.3	1uobA-4j25A: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	4lt5	NAEGLERIA TET-LIKE DIOXYGENASE (Naegleria gruberi)	5 / 12	HIS A 229 ASP A 231 LEU A 253 HIS A 279 VAL A 293	MN A 401 ( 3.4A) MN A 401 ( 2.7A) OGA A 413 (-3.8A) MN A 401 ( 3.4A) OGA A 413 (-4.9A)	0.68A	1uobA-4lt5A: 8.2	1uobA-4lt5A: 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 12	HIS A1382 ASP A1384 HIS A1881 SER A1898 VAL A1900	FE A2003 (-3.3A) FE A2003 ( 2.4A) FE A2003 ( 3.2A) OGA A2001 (-2.7A) OGA A2001 ( 4.9A)	0.61A	1uobA-5deuA: 7.6	1uobA-5deuA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 12	SER A1286 HIS A1881 LEU A1872 SER A1898 VAL A1900	None FE A2003 ( 3.2A) None OGA A2001 (-2.7A) OGA A2001 ( 4.9A)	1.50A	1uobA-5deuA: 7.6	1uobA-5deuA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOB_A_PNNA1311_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	5 / 12	HIS A 189 ASP A 191 LEU A 206 HIS A 268 PHE A 283	FE A 401 (-3.3A) FE A 401 (-2.4A) OGA A 402 (-3.5A) FE A 401 ( 3.2A) ARG A 403 ( 4.2A)	0.50A	1uobA-5lunA: 21.1	1uobA-5lunA: 22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	2rds	1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE FE(II)/ALPHA-KETOGL UTARATE DEPENDENT HYDROXYLASE (Streptomyces avermitilis)	5 / 11	HIS A 137 ASP A 139 HIS A 226 ARG A 240 SER A 242	FE A 1 (-3.4A) FE A 1 ( 2.6A) FE A 1 ( 3.4A) OGA A 268 (-2.9A) OGA A 268 ( 4.5A)	1.03A	1uofA-2rdsA: 5.7	1uofA-2rdsA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	2rds	1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE FE(II)/ALPHA-KETOGL UTARATE DEPENDENT HYDROXYLASE (Streptomyces avermitilis)	5 / 11	HIS A 137 ASP A 139 THR A 151 HIS A 226 SER A 242	FE A 1 (-3.4A) FE A 1 ( 2.6A) OGA A 268 (-3.8A) FE A 1 ( 3.4A) OGA A 268 ( 4.5A)	0.64A	1uofA-2rdsA: 5.7	1uofA-2rdsA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	2rds	1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE FE(II)/ALPHA-KETOGL UTARATE DEPENDENT HYDROXYLASE (Streptomyces avermitilis)	5 / 11	PHE A 73 HIS A 137 ASP A 139 THR A 151 HIS A 226	None FE A 1 (-3.4A) FE A 1 ( 2.6A) OGA A 268 (-3.8A) FE A 1 ( 3.4A)	0.88A	1uofA-2rdsA: 5.7	1uofA-2rdsA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	4j25	PUTATIVE UNCHARACTERIZED PROTEIN (Pseudomonas putida)	6 / 11	HIS A 124 ASP A 126 HIS A 183 VAL A 185 SER A 194 VAL A 139	MN A 401 ( 3.3A) MN A 401 ( 2.6A) MN A 401 ( 3.3A) None OGA A 402 ( 3.7A) OGA A 402 ( 4.9A)	1.36A	1uofA-4j25A: 9.4	1uofA-4j25A: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	4lt5	NAEGLERIA TET-LIKE DIOXYGENASE (Naegleria gruberi)	5 / 11	HIS A 229 ASP A 231 HIS A 279 VAL A 281 VAL A 293	MN A 401 ( 3.4A) MN A 401 ( 2.7A) MN A 401 ( 3.4A) OGA A 413 (-4.8A) OGA A 413 (-4.9A)	0.60A	1uofA-4lt5A: 2.7	1uofA-4lt5A: 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 11	HIS A1382 ASP A1384 ARG A1896 SER A1898 VAL A1900	FE A2003 (-3.3A) FE A2003 ( 2.4A) OGA A2001 (-2.9A) OGA A2001 (-2.7A) OGA A2001 ( 4.9A)	1.00A	1uofA-5deuA: 7.1	1uofA-5deuA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 11	HIS A1382 ASP A1384 HIS A1881 SER A1898 VAL A1900	FE A2003 (-3.3A) FE A2003 ( 2.4A) FE A2003 ( 3.2A) OGA A2001 (-2.7A) OGA A2001 ( 4.9A)	0.79A	1uofA-5deuA: 7.1	1uofA-5deuA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 11	HIS A1382 THR A1393 HIS A1881 SER A1898 VAL A1900	FE A2003 (-3.3A) CL A2007 (-4.5A) FE A2003 ( 3.2A) OGA A2001 (-2.7A) OGA A2001 ( 4.9A)	0.74A	1uofA-5deuA: 7.1	1uofA-5deuA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPOR IN C SYNTHETASE)	5jz8	ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (Homo sapiens)	5 / 11	HIS A 679 HIS A 725 VAL A 727 ARG A 735 SER A 668	MN A 801 ( 3.4A) MN A 801 ( 3.4A) OGA A 802 ( 4.9A) OGA A 802 (-2.2A) OGA A 802 (-2.5A)	1.18A	1uofA-5jz8A: 6.9	1uofA-5jz8A: 20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BM9_A_SAMA301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	6fqc	BIFUNCTIONAL ARGININE DEMETHYLASE AND LYSYL-HYDROXYLASE JMJD6 (Homo sapiens)	3 / 3	LYS A 204 ASP A 189 ASN A 197	OGA A 506 (-2.9A) MN A 501 ( 2.6A) OGA A 506 (-3.6A)	1.13A	2bm9A-6fqcA: undetectable	2bm9A-6fqcA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXP_A_P1ZA3001_1 (SERUM ALBUMIN)	2xdv	MYC-INDUCED NUCLEAR ANTIGEN (Homo sapiens)	5 / 12	LEU A 198 PHE A 234 LEU A 226 ILE A 187 ALA A 242	None None None None OGA A 601 ( 4.2A)	1.18A	2bxpA-2xdvA: undetectable	2bxpA-2xdvA: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	2xdv	MYC-INDUCED NUCLEAR ANTIGEN (Homo sapiens)	5 / 12	SER A 257 PRO A 140 THR A 255 VAL A 254 ILE A 150	None None OGA A 601 (-3.0A) None None	1.42A	2fj1A-2xdvA: undetectable	2fj1A-2xdvA: 18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FQY_A_ADNA400_1 (MEMBRANE LIPOPROTEIN TMPC)	5jz8	ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE COAGULATION FACTOR X (Homo sapiens)	5 / 12	GLY A 663 ASP A 741 PHE A 719 GLY A 681 ASP B 103	None None OGA A 802 (-4.9A) None OGA A 802 ( 3.2A)	1.25A	2fqyA-5jz8A: undetectable	2fqyA-5jz8A: 22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCT_A_ASDA1223_1 (GLUTATHIONE S-TRANSFERASE A2)	3n9o	PUTATIVE UNCHARACTERIZED PROTEIN (Caenorhabditis elegans)	4 / 8	GLY A 579 LEU A 484 LEU A 423 PHE A 498	None None OGA A 4 (-4.4A) None	0.73A	2vctA-3n9oA: 3.5	2vctA-3n9oA: 18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCT_B_ASDB1223_1 (GLUTATHIONE S-TRANSFERASE A2)	3n9o	PUTATIVE UNCHARACTERIZED PROTEIN (Caenorhabditis elegans)	4 / 8	GLY A 579 LEU A 484 LEU A 423 PHE A 498	None None OGA A 4 (-4.4A) None	0.75A	2vctB-3n9oA: 5.0	2vctB-3n9oA: 18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZS9_A_PAUA603_0 (PANTOTHENATE KINASE)	3kv4	PHD FINGER PROTEIN 8 (Homo sapiens)	4 / 6	ASP A 249 HIS A 319 TYR A 257 ASN A 189	FE2 A 450 ( 2.5A) FE2 A 450 ( 3.4A) OGA A5798 (-4.2A) OGA A5798 (-3.7A)	1.14A	2zs9A-3kv4A: undetectable	2zs9A-3kv4A: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZS9_A_PAUA603_0 (PANTOTHENATE KINASE)	3n9o	PUTATIVE UNCHARACTERIZED PROTEIN (Caenorhabditis elegans)	4 / 6	ASP A 497 HIS A 567 TYR A 505 ASN A 421	FE2 A 1 ( 2.6A) FE2 A 1 ( 3.3A) OGA A 4 (-4.1A) OGA A 4 (-4.0A)	1.16A	2zs9A-3n9oA: undetectable	2zs9A-3n9oA: 19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZS9_A_PAUA603_0 (PANTOTHENATE KINASE)	4lt5	NAEGLERIA TET-LIKE DIOXYGENASE (Naegleria gruberi)	4 / 6	VAL A 293 ASP A 234 HIS A 297 ASN A 214	OGA A 413 (-4.9A) None None OGA A 413 (-3.3A)	1.36A	2zs9A-4lt5A: undetectable	2zs9A-4lt5A: 20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AVO_A_PAUA314_0 (PANTOTHENATE KINASE)	4lt5	NAEGLERIA TET-LIKE DIOXYGENASE (Naegleria gruberi)	5 / 11	VAL A 293 ASP A 234 HIS A 297 ILE A 225 ASN A 214	OGA A 413 (-4.9A) None None OGA A 413 (-4.1A) OGA A 413 (-3.3A)	1.49A	3avoA-4lt5A: undetectable	3avoA-4lt5A: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IHZ_A_FK5A501_2 (70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	4 / 8	ASP A1376 TYR A1245 SER A1898 ILE A1897	None None OGA A2001 (-2.7A) None	0.89A	3ihzB-5deuA: undetectable	3ihzB-5deuA: 14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KCX_A_CQLA1_0 (HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR)	3kv4	PHD FINGER PROTEIN 8 (Homo sapiens)	7 / 10	LEU A 236 THR A 244 HIS A 247 ASP A 249 LYS A 264 ILE A 313 HIS A 319	OGA A5798 ( 4.8A) OGA A5798 (-3.4A) FE2 A 450 ( 3.4A) FE2 A 450 ( 2.5A) OGA A5798 (-2.8A) None FE2 A 450 ( 3.4A)	0.98A	3kcxA-3kv4A: 16.7	3kcxA-3kv4A: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KCX_A_CQLA1_0 (HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR)	3n9o	PUTATIVE UNCHARACTERIZED PROTEIN (Caenorhabditis elegans)	6 / 10	LEU A 484 THR A 492 HIS A 495 ASP A 497 LYS A 512 HIS A 567	None OGA A 4 (-3.7A) FE2 A 1 ( 3.3A) FE2 A 1 ( 2.6A) OGA A 4 (-3.5A) FE2 A 1 ( 3.3A)	0.89A	3kcxA-3n9oA: 16.3	3kcxA-3n9oA: 20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KCX_A_CQLA1_0 (HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR)	3pua	PHD FINGER PROTEIN 2 (Homo sapiens)	6 / 10	LEU A 238 THR A 246 HIS A 249 ASP A 251 LYS A 266 ILE A 315	OGA A 454 ( 3.8A) OGA A 454 (-3.8A) NI A 2 ( 3.3A) NI A 2 ( 2.5A) OGA A 454 (-3.0A) None	0.90A	3kcxA-3puaA: 17.1	3kcxA-3puaA: 23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KCX_A_CQLA1_0 (HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR)	3pua	PHD FINGER PROTEIN 2 (Homo sapiens)	5 / 10	LEU A 238 THR A 323 HIS A 249 ASP A 251 ILE A 315	OGA A 454 ( 3.8A) OGA A 454 (-2.9A) NI A 2 ( 3.3A) NI A 2 ( 2.5A) None	1.23A	3kcxA-3puaA: 17.1	3kcxA-3puaA: 23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KCX_A_CQLA1_0 (HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR)	4c8d	LYSINE-SPECIFIC DEMETHYLASE 3B (Homo sapiens)	5 / 10	THR A1557 HIS A1560 ASP A1562 ILE A1683 HIS A1689	OGA A2722 (-3.3A) MN A2721 ( 3.3A) MN A2721 ( 3.0A) None MN A2721 ( 3.2A)	0.50A	3kcxA-4c8dA: 14.3	3kcxA-4c8dA: 19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KCX_A_CQLA1_0 (HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR)	4qkf	ALPHA-KETOGLUTARATE- DEPENDENT DIOXYGENASE ALKB HOMOLOG 7, MITOCHONDRIAL (Homo sapiens)	5 / 10	LEU A 110 HIS A 121 ASP A 123 HIS A 177 ILE A 179	OGA A 301 ( 4.6A) MN A 300 ( 3.4A) MN A 300 (-2.9A) MN A 300 ( 3.5A) None	1.10A	3kcxA-4qkfA: 8.9	3kcxA-4qkfA: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_D_CLMD221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	4eyu	LYSINE-SPECIFIC DEMETHYLASE 6B (Mus musculus)	5 / 12	SER A1398 PHE A1454 VAL A1462 ALA A1412 HIS A1390	OGA A1700 (-2.8A) None None None NI A1701 ( 3.3A)	1.35A	3u9fD-4eyuA: undetectable 3u9fE-4eyuA: undetectable	3u9fD-4eyuA: 16.46 3u9fE-4eyuA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_G_CLMG221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	4eyu	LYSINE-SPECIFIC DEMETHYLASE 6B (Mus musculus)	5 / 12	SER A1398 PHE A1454 VAL A1462 ALA A1412 HIS A1390	OGA A1700 (-2.8A) None None None NI A1701 ( 3.3A)	1.32A	3u9fG-4eyuA: undetectable 3u9fH-4eyuA: undetectable	3u9fG-4eyuA: 16.46 3u9fH-4eyuA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UJ7_B_SAMB302_1 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	2pxj	JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROTEIN 3A (Homo sapiens)	4 / 5	TYR A 141 SER A 288 ASP A 61 ILE A 62	None OGA A5001 (-3.5A) None None	1.34A	3uj7B-2pxjA: undetectable	3uj7B-2pxjA: 23.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J6D_A_TESA503_1 (CYTOCHROME P450 MONOOXYGENASE)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	5 / 12	PHE A 250 GLN A 200 ALA A 279 ALA A 198 ALA A 281	None None OGA A 402 (-3.6A) OGA A 402 ( 4.2A) OGA A 402 ( 3.7A)	1.08A	4j6dA-5lunA: undetectable	4j6dA-5lunA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J6D_B_TESB502_1 (CYTOCHROME P450 MONOOXYGENASE)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	5 / 12	PHE A 250 GLN A 200 ALA A 279 ALA A 198 ALA A 281	None None OGA A 402 (-3.6A) OGA A 402 ( 4.2A) OGA A 402 ( 3.7A)	1.08A	4j6dB-5lunA: undetectable	4j6dB-5lunA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JBT_A_ASDA501_1 (CYTOCHROME P450 MONOOXYGENASE)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	5 / 12	PHE A 250 GLN A 200 ALA A 279 ALA A 198 ALA A 281	None None OGA A 402 (-3.6A) OGA A 402 ( 4.2A) OGA A 402 ( 3.7A)	1.10A	4jbtA-5lunA: undetectable	4jbtA-5lunA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOT_A_CE3A205_1 (UNCHARACTERIZED PROTEIN)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	5 / 12	PHE A 283 ARG A 321 GLY A 77 TYR A 126 LEU A 173	ARG A 403 ( 4.2A) None None None OGA A 402 (-4.5A)	1.50A	4kotA-5lunA: undetectable	4kotA-5lunA: 20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOW_A_CFXA204_1 (UNCHARACTERIZED PROTEIN)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	5 / 12	PHE A 283 ARG A 321 GLY A 77 TYR A 126 LEU A 173	ARG A 403 ( 4.2A) None None None OGA A 402 (-4.5A)	1.50A	4kowA-5lunA: undetectable	4kowA-5lunA: 20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LRH_D_FOLD301_1 (FOLATE RECEPTOR ALPHA)	3avs	LYSINE-SPECIFIC DEMETHYLASE 6A (Homo sapiens)	3 / 3	HIS A1226 TRP A1194 SER A1154	NI A1503 ( 3.4A) None OGA A1501 (-2.7A)	1.17A	4lrhD-3avsA: undetectable	4lrhD-3avsA: 17.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LRH_D_FOLD301_1 (FOLATE RECEPTOR ALPHA)	4eyu	LYSINE-SPECIFIC DEMETHYLASE 6B (Mus musculus)	3 / 3	HIS A1470 TRP A1438 SER A1398	NI A1701 ( 3.1A) None OGA A1700 (-2.8A)	1.16A	4lrhD-4eyuA: undetectable	4lrhD-4eyuA: 18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4qkf	ALPHA-KETOGLUTARATE- DEPENDENT DIOXYGENASE ALKB HOMOLOG 7, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 110 LEU A 145 ILE A 179 ILE A 70 ALA A 69	OGA A 301 ( 4.6A) None None None None	1.09A	4ltwA-4qkfA: undetectable	4ltwA-4qkfA: 23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8F_B_BRLB501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2pxj	JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROTEIN 3A (Homo sapiens)	5 / 12	SER A 196 LEU A 44 VAL A 260 PHE A 185 HIS A 188	OGA A5001 (-2.7A) None None OGA A5001 (-3.8A) FE2 A3001 ( 3.5A)	1.22A	4o8fB-2pxjA: undetectable	4o8fB-2pxjA: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QZT_A_RTLA201_0 (RETINOL-BINDING PROTEIN 2)	4bhi	GAMMA-BUTYROBETAINE DIOXYGENASE (Homo sapiens)	5 / 12	ILE A 358 TYR A 194 GLN A 215 LEU A 217 LEU A 362	None RUJ A 401 (-4.3A) ZN A 402 ( 4.2A) None OGA A 400 (-4.9A)	1.43A	4qztA-4bhiA: undetectable	4qztA-4bhiA: 17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YHA_B_MZMB303_1 (ALPHA-CARBONIC ANHYDRASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 10	HIS A1416 HIS A1881 VAL A1395 VAL A1900 ALA A1379	OGA A2001 (-3.9A) FE A2003 ( 3.2A) OGA A2001 ( 4.9A) OGA A2001 ( 4.9A) OGA A2001 ( 4.4A)	1.36A	4yhaB-5deuA: undetectable	4yhaB-5deuA: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YHA_G_MZMG303_1 (ALPHA-CARBONIC ANHYDRASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 12	HIS A1416 HIS A1881 VAL A1395 VAL A1900 ALA A1379	OGA A2001 (-3.9A) FE A2003 ( 3.2A) OGA A2001 ( 4.9A) OGA A2001 ( 4.9A) OGA A2001 ( 4.4A)	1.49A	4yhaG-5deuA: undetectable	4yhaG-5deuA: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DV4_A_NMYA601_1 (CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE)	6fqc	BIFUNCTIONAL ARGININE DEMETHYLASE AND LYSYL-HYDROXYLASE JMJD6 (Homo sapiens)	5 / 12	TYR A 131 PRO A 171 ASP A 189 ASN A 287 HIS A 187	None None MN A 501 ( 2.6A) OGA A 506 ( 4.6A) MN A 501 ( 3.4A)	1.38A	5dv4A-6fqcA: undetectable	5dv4A-6fqcA: 12.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECM_A_LEUA602_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	3pua	PHD FINGER PROTEIN 2 (Homo sapiens)	4 / 5	THR A 246 ALA A 322 THR A 323 HIS A 249	OGA A 454 (-3.8A) None OGA A 454 (-2.9A) NI A 2 ( 3.3A)	1.22A	5ecmA-3puaA: undetectable	5ecmA-3puaA: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KC0_A_RBFA303_1 (RIBOFLAVIN TRANSPORTER RIBU)	4bhi	GAMMA-BUTYROBETAINE DIOXYGENASE (Homo sapiens)	5 / 12	GLU A 230 LEU A 199 ALA A 294 ASN A 292 PHE A 291	None OGA A 400 (-4.8A) None RUJ A 401 (-4.1A) None	1.43A	5kc0A-4bhiA: undetectable	5kc0A-4bhiA: 19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TT3_E_EZLE303_1 (ALPHA-CARBONIC ANHYDRASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 9	HIS A1416 HIS A1881 VAL A1395 VAL A1900 ALA A1379	OGA A2001 (-3.9A) FE A2003 ( 3.2A) OGA A2001 ( 4.9A) OGA A2001 ( 4.9A) OGA A2001 ( 4.4A)	1.42A	5tt3E-5deuA: undetectable	5tt3E-5deuA: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TT3_G_EZLG303_1 (ALPHA-CARBONIC ANHYDRASE)	5deu	METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT (Homo sapiens)	5 / 9	HIS A1416 HIS A1881 VAL A1395 VAL A1900 ALA A1379	OGA A2001 (-3.9A) FE A2003 ( 3.2A) OGA A2001 ( 4.9A) OGA A2001 ( 4.9A) OGA A2001 ( 4.4A)	1.46A	5tt3G-5deuA: undetectable	5tt3G-5deuA: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF0_A_SAMA505_0 (CARNOSINE N-METHYLTRANSFERASE)	2rds	1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE FE(II)/ALPHA-KETOGL UTARATE DEPENDENT HYDROXYLASE (Streptomyces avermitilis)	5 / 12	GLY A 164 GLY A 165 ASN A 231 SER A 242 TYR A 8	None None None OGA A 268 ( 4.5A) None	1.24A	5yf0A-2rdsA: undetectable	5yf0A-2rdsA: 19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DK1_C_GM4C301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5lun	2-OXOGLUTARATE-DEPEN DENT ETHYLENE/SUCCINATE-F ORMING ENZYME (Pseudomonas savastanoi)	5 / 11	ALA A 281 TYR A 318 ASP A 91 GLU A 84 THR A 97	OGA A 402 ( 3.7A) None ARG A 403 ( 4.7A) ARG A 403 (-3.5A) None	1.22A	6dk1C-5lunA: 4.3	6dk1C-5lunA: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_S_PCFS603_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 8 CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL)	3avs	LYSINE-SPECIFIC DEMETHYLASE 6A (Homo sapiens)	4 / 7	GLN A1133 GLY A1128 VAL A1268 SER A1154	None None None OGA A1501 (-2.7A)	0.80A	6hu9S-3avsA: undetectable 6hu9q-3avsA: undetectable	6hu9S-3avsA: 10.12 6hu9q-3avsA: 12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_S_PCFS603_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 8 CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL)	4eyu	LYSINE-SPECIFIC DEMETHYLASE 6B (Mus musculus)	4 / 7	GLN A1377 GLY A1372 VAL A1512 SER A1398	None None None OGA A1700 (-2.8A)	0.89A	6hu9S-4eyuA: undetectable 6hu9q-4eyuA: undetectable	6hu9S-4eyuA: 10.74 6hu9q-4eyuA: 14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MA7_A_TPFA602_0 (CYTOCHROME P450 3A4)	4qkf	ALPHA-KETOGLUTARATE- DEPENDENT DIOXYGENASE ALKB HOMOLOG 7, MITOCHONDRIAL (Homo sapiens)	4 / 7	ARG A 191 ARG A 197 ALA A 114 ILE A 179	None OGA A 301 (-3.0A) None None	0.95A	6ma7A-4qkfA: undetectable	6ma7A-4qkfA: 13.76

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A4L_A_DCFA353_1","ADENOSINE DEAMINASE","4bhi","GAMMA-BUTYROBETAINE DIOXYGENASE","Homo sapiens",5,"HIS A 202;ASP A 261;ALA A 193;HIS A 347;ASP A 204"," ZN A 402 ( 3.3A);RUJ A 401 ( 4.7A);OGA A 400 (-3.1A); ZN A 402 ( 3.3A); ZN A 402 (-2.6A)","1.26A","1a4lA-4bhiA:undetectable",null],["1A4L_C_DCFC1353_1","ADENOSINE DEAMINASE","4bhi","GAMMA-BUTYROBETAINE DIOXYGENASE","Homo sapiens",5,"HIS A 202;ASP A 261;ALA A 193;HIS A 347;ASP A 204"," ZN A 402 ( 3.3A);RUJ A 401 ( 4.7A);OGA A 400 (-3.1A); ZN A 402 ( 3.3A); ZN A 402 (-2.6A)","1.25A","1a4lC-4bhiA:undetectable","1a4lA-4bhiA:22.15"],["1EI6_A_PPFA410_1","PHOSPHONOACETATE HYDROLASE","2rds"," FE(II)\/ALPHA-KETOGLUTARATE DEPENDENT HYDROXYLASE;1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE","Streptomyces avermitilis",4,"THR A 151;ASP A 139;HIS A 137;HIS A 226","OGA A 268 (-3.8A); FE A   1 ( 2.6A); FE A   1 (-3.4A); FE A   1 ( 3.4A)","1.16A","1ei6A-2rdsA:undetectable","1a4lC-4bhiA:22.15"],["1MEI_A_MOAA600_1","INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE","5jz8","ASPARTYL\/ASPARAGINYL BETA-HYDROXYLASE","Homo sapiens",4,"ASP A 721;SER A 722;SER A 563;ARG A 662","OGA A 802 ( 4.8A);None;None;None","0.95A","1meiA-5jz8A:undetectable","1ei6A-2rdsA:21.98"],["1ONI_D_BEZD507_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",4,"ARG A 277;ALA A 279;ILE A 186;ILE A  95","OGA A 402 (-2.7A);OGA A 402 (-3.6A);ARG A 403 (-4.7A);None","0.79A","1oniD-5lunA:undetectable;1oniF-5lunA:undetectable","1meiA-5jz8A:20.31"],["1Q23_A_FUAA702_1","CHLORAMPHENICOL ACETYLTRANSFERASE;CHLORAMPHENICOL ACETYLTRANSFERASE","3pua","PHD FINGER PROTEIN 2","Homo sapiens",5,"THR A 325;TYR A 259;PHE A 268;SER A 244;ALA A 333","None;OGA A 454 (-4.6A);None;None;EDO A   9 ( 3.9A)","1.29A","1q23A-3puaA:undetectable;1q23B-3puaA:undetectable","1oniD-5lunA:17.01;1oniF-5lunA:17.01"],["1UOB_A_PNNA1311_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","2rds","1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE; FE(II)\/ALPHA-KETOGLUTARATE DEPENDENT HYDROXYLASE","Streptomyces avermitilis",5,"LEU A 218;HIS A 137;ASP A 139;SER A 172;PHE A 220","None; FE A   1 (-3.4A); FE A   1 ( 2.6A);None;OGA A 268 (-4.9A)","1.46A","1uobA-2rdsA:9.9","1q23A-3puaA:18.25;1q23B-3puaA:18.25"],["1UOB_A_PNNA1311_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","4j25","PUTATIVE UNCHARACTERIZED PROTEIN","Pseudomonas putida",5,"HIS A 124;ASP A 126;HIS A 183;SER A 194;VAL A 139"," MN A 401 ( 3.3A); MN A 401 ( 2.6A); MN A 401 ( 3.3A);OGA A 402 ( 3.7A);OGA A 402 ( 4.9A)","1.44A","1uobA-4j25A:10.3","1uobA-2rdsA:25.00"],["1UOB_A_PNNA1311_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","4j25","PUTATIVE UNCHARACTERIZED PROTEIN","Pseudomonas putida",5,"HIS A 124;ASP A 126;LEU A 154;HIS A 183;SER A 194"," MN A 401 ( 3.3A); MN A 401 ( 2.6A);OGA A 402 (-3.7A); MN A 401 ( 3.3A);OGA A 402 ( 3.7A)","0.61A","1uobA-4j25A:10.3","1uobA-4j25A:21.54"],["1UOB_A_PNNA1311_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","4lt5","NAEGLERIA TET-LIKE DIOXYGENASE","Naegleria gruberi",5,"HIS A 229;ASP A 231;LEU A 253;HIS A 279;VAL A 293"," MN A 401 ( 3.4A); MN A 401 ( 2.7A);OGA A 413 (-3.8A); MN A 401 ( 3.4A);OGA A 413 (-4.9A)","0.68A","1uobA-4lt5A:8.2","1uobA-4j25A:21.54"],["1UOB_A_PNNA1311_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1382;ASP A1384;HIS A1881;SER A1898;VAL A1900"," FE A2003 (-3.3A); FE A2003 ( 2.4A); FE A2003 ( 3.2A);OGA A2001 (-2.7A);OGA A2001 ( 4.9A)","0.61A","1uobA-5deuA:7.6","1uobA-4lt5A:21.63"],["1UOB_A_PNNA1311_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"SER A1286;HIS A1881;LEU A1872;SER A1898;VAL A1900","None; FE A2003 ( 3.2A);None;OGA A2001 (-2.7A);OGA A2001 ( 4.9A)","1.50A","1uobA-5deuA:7.6","1uobA-5deuA:21.54"],["1UOB_A_PNNA1311_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",5,"HIS A 189;ASP A 191;LEU A 206;HIS A 268;PHE A 283"," FE A 401 (-3.3A); FE A 401 (-2.4A);OGA A 402 (-3.5A); FE A 401 ( 3.2A);ARG A 403 ( 4.2A)","0.50A","1uobA-5lunA:21.1","1uobA-5deuA:21.54"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","2rds","1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE; FE(II)\/ALPHA-KETOGLUTARATE DEPENDENT HYDROXYLASE","Streptomyces avermitilis",5,"HIS A 137;ASP A 139;HIS A 226;ARG A 240;SER A 242"," FE A   1 (-3.4A); FE A   1 ( 2.6A); FE A   1 ( 3.4A);OGA A 268 (-2.9A);OGA A 268 ( 4.5A)","1.03A","1uofA-2rdsA:5.7","1uobA-5lunA:22.51"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","2rds","1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE; FE(II)\/ALPHA-KETOGLUTARATE DEPENDENT HYDROXYLASE","Streptomyces avermitilis",5,"HIS A 137;ASP A 139;THR A 151;HIS A 226;SER A 242"," FE A   1 (-3.4A); FE A   1 ( 2.6A);OGA A 268 (-3.8A); FE A   1 ( 3.4A);OGA A 268 ( 4.5A)","0.64A","1uofA-2rdsA:5.7","1uofA-2rdsA:25.00"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","2rds","1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE; FE(II)\/ALPHA-KETOGLUTARATE DEPENDENT HYDROXYLASE","Streptomyces avermitilis",5,"PHE A  73;HIS A 137;ASP A 139;THR A 151;HIS A 226","None; FE A   1 (-3.4A); FE A   1 ( 2.6A);OGA A 268 (-3.8A); FE A   1 ( 3.4A)","0.88A","1uofA-2rdsA:5.7","1uofA-2rdsA:25.00"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","4j25","PUTATIVE UNCHARACTERIZED PROTEIN","Pseudomonas putida",6,"HIS A 124;ASP A 126;HIS A 183;VAL A 185;SER A 194;VAL A 139"," MN A 401 ( 3.3A); MN A 401 ( 2.6A); MN A 401 ( 3.3A);None;OGA A 402 ( 3.7A);OGA A 402 ( 4.9A)","1.36A","1uofA-4j25A:9.4","1uofA-2rdsA:25.00"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","4lt5","NAEGLERIA TET-LIKE DIOXYGENASE","Naegleria gruberi",5,"HIS A 229;ASP A 231;HIS A 279;VAL A 281;VAL A 293"," MN A 401 ( 3.4A); MN A 401 ( 2.7A); MN A 401 ( 3.4A);OGA A 413 (-4.8A);OGA A 413 (-4.9A)","0.60A","1uofA-4lt5A:2.7","1uofA-4j25A:21.54"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1382;ASP A1384;ARG A1896;SER A1898;VAL A1900"," FE A2003 (-3.3A); FE A2003 ( 2.4A);OGA A2001 (-2.9A);OGA A2001 (-2.7A);OGA A2001 ( 4.9A)","1.00A","1uofA-5deuA:7.1","1uofA-4lt5A:21.63"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1382;ASP A1384;HIS A1881;SER A1898;VAL A1900"," FE A2003 (-3.3A); FE A2003 ( 2.4A); FE A2003 ( 3.2A);OGA A2001 (-2.7A);OGA A2001 ( 4.9A)","0.79A","1uofA-5deuA:7.1","1uofA-5deuA:21.54"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1382;THR A1393;HIS A1881;SER A1898;VAL A1900"," FE A2003 (-3.3A); CL A2007 (-4.5A); FE A2003 ( 3.2A);OGA A2001 (-2.7A);OGA A2001 ( 4.9A)","0.74A","1uofA-5deuA:7.1","1uofA-5deuA:21.54"],["1UOF_A_PNNA1312_0","DEACETOXYCEPHALOSPORIN C SYNTHETASE","5jz8","ASPARTYL\/ASPARAGINYL BETA-HYDROXYLASE","Homo sapiens",5,"HIS A 679;HIS A 725;VAL A 727;ARG A 735;SER A 668"," MN A 801 ( 3.4A); MN A 801 ( 3.4A);OGA A 802 ( 4.9A);OGA A 802 (-2.2A);OGA A 802 (-2.5A)","1.18A","1uofA-5jz8A:6.9","1uofA-5deuA:21.54"],["2BM9_A_SAMA301_1","CEPHALOSPORIN HYDROXYLASE CMCI","6fqc","BIFUNCTIONAL ARGININE DEMETHYLASE AND LYSYL-HYDROXYLASE JMJD6","Homo sapiens",3,"LYS A 204;ASP A 189;ASN A 197","OGA A 506 (-2.9A); MN A 501 ( 2.6A);OGA A 506 (-3.6A)","1.13A","2bm9A-6fqcA:undetectable","1uofA-5jz8A:20.18"],["2BXP_A_P1ZA3001_1","SERUM ALBUMIN","2xdv","MYC-INDUCED NUCLEAR ANTIGEN","Homo sapiens",5,"LEU A 198;PHE A 234;LEU A 226;ILE A 187;ALA A 242","None;None;None;None;OGA A 601 ( 4.2A)","1.18A","2bxpA-2xdvA:undetectable","2bm9A-6fqcA:undetectable"],["2FJ1_A_CTCA222_0","TETRACYCLINE REPRESSOR PROTEIN CLASS D","2xdv","MYC-INDUCED NUCLEAR ANTIGEN","Homo sapiens",5,"SER A 257;PRO A 140;THR A 255;VAL A 254;ILE A 150","None;None;OGA A 601 (-3.0A);None;None","1.42A","2fj1A-2xdvA:undetectable","2bxpA-2xdvA:22.08"],["2FQY_A_ADNA400_1","MEMBRANE LIPOPROTEIN TMPC","5jz8","ASPARTYL\/ASPARAGINYL BETA-HYDROXYLASE;COAGULATION FACTOR X","Homo sapiens",5,"GLY A 663;ASP A 741;PHE A 719;GLY A 681;ASP B 103","None;None;OGA A 802 (-4.9A);None;OGA A 802 ( 3.2A)","1.25A","2fqyA-5jz8A:undetectable","2fj1A-2xdvA:18.83"],["2VCT_A_ASDA1223_1","GLUTATHIONE S-TRANSFERASE A2","3n9o","PUTATIVE UNCHARACTERIZED PROTEIN","Caenorhabditis elegans",4,"GLY A 579;LEU A 484;LEU A 423;PHE A 498","None;None;OGA A   4 (-4.4A);None","0.73A","2vctA-3n9oA:3.5","2fqyA-5jz8A:22.37"],["2VCT_B_ASDB1223_1","GLUTATHIONE S-TRANSFERASE A2","3n9o","PUTATIVE UNCHARACTERIZED PROTEIN","Caenorhabditis elegans",4,"GLY A 579;LEU A 484;LEU A 423;PHE A 498","None;None;OGA A   4 (-4.4A);None","0.75A","2vctB-3n9oA:5.0","2vctA-3n9oA:18.58"],["2ZS9_A_PAUA603_0","PANTOTHENATE KINASE","3kv4","PHD FINGER PROTEIN 8","Homo sapiens",4,"ASP A 249;HIS A 319;TYR A 257;ASN A 189","FE2 A 450 ( 2.5A);FE2 A 450 ( 3.4A);OGA A5798 (-4.2A);OGA A5798 (-3.7A)","1.14A","2zs9A-3kv4A:undetectable","2vctB-3n9oA:18.58"],["2ZS9_A_PAUA603_0","PANTOTHENATE KINASE","3n9o","PUTATIVE UNCHARACTERIZED PROTEIN","Caenorhabditis elegans",4,"ASP A 497;HIS A 567;TYR A 505;ASN A 421","FE2 A   1 ( 2.6A);FE2 A   1 ( 3.3A);OGA A   4 (-4.1A);OGA A   4 (-4.0A)","1.16A","2zs9A-3n9oA:undetectable","2zs9A-3kv4A:21.96"],["2ZS9_A_PAUA603_0","PANTOTHENATE KINASE","4lt5","NAEGLERIA TET-LIKE DIOXYGENASE","Naegleria gruberi",4,"VAL A 293;ASP A 234;HIS A 297;ASN A 214","OGA A 413 (-4.9A);None;None;OGA A 413 (-3.3A)","1.36A","2zs9A-4lt5A:undetectable","2zs9A-3n9oA:19.66"],["3AVO_A_PAUA314_0","PANTOTHENATE KINASE","4lt5","NAEGLERIA TET-LIKE DIOXYGENASE","Naegleria gruberi",5,"VAL A 293;ASP A 234;HIS A 297;ILE A 225;ASN A 214","OGA A 413 (-4.9A);None;None;OGA A 413 (-4.1A);OGA A 413 (-3.3A)","1.49A","3avoA-4lt5A:undetectable","2zs9A-4lt5A:20.28"],["3IHZ_A_FK5A501_2","70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE;70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",4,"ASP A1376;TYR A1245;SER A1898;ILE A1897","None;None;OGA A2001 (-2.7A);None","0.89A","3ihzB-5deuA:undetectable","3avoA-4lt5A:21.88"],["3KCX_A_CQLA1_0","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","3kv4","PHD FINGER PROTEIN 8","Homo sapiens",7,"LEU A 236;THR A 244;HIS A 247;ASP A 249;LYS A 264;ILE A 313;HIS A 319","OGA A5798 ( 4.8A);OGA A5798 (-3.4A);FE2 A 450 ( 3.4A);FE2 A 450 ( 2.5A);OGA A5798 (-2.8A);None;FE2 A 450 ( 3.4A)","0.98A","3kcxA-3kv4A:16.7","3ihzB-5deuA:14.10"],["3KCX_A_CQLA1_0","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","3n9o","PUTATIVE UNCHARACTERIZED PROTEIN","Caenorhabditis elegans",6,"LEU A 484;THR A 492;HIS A 495;ASP A 497;LYS A 512;HIS A 567","None;OGA A   4 (-3.7A);FE2 A   1 ( 3.3A);FE2 A   1 ( 2.6A);OGA A   4 (-3.5A);FE2 A   1 ( 3.3A)","0.89A","3kcxA-3n9oA:16.3","3kcxA-3kv4A:20.75"],["3KCX_A_CQLA1_0","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","3pua","PHD FINGER PROTEIN 2","Homo sapiens",6,"LEU A 238;THR A 246;HIS A 249;ASP A 251;LYS A 266;ILE A 315","OGA A 454 ( 3.8A);OGA A 454 (-3.8A); NI A   2 ( 3.3A); NI A   2 ( 2.5A);OGA A 454 (-3.0A);None","0.90A","3kcxA-3puaA:17.1","3kcxA-3n9oA:20.37"],["3KCX_A_CQLA1_0","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","3pua","PHD FINGER PROTEIN 2","Homo sapiens",5,"LEU A 238;THR A 323;HIS A 249;ASP A 251;ILE A 315","OGA A 454 ( 3.8A);OGA A 454 (-2.9A); NI A   2 ( 3.3A); NI A   2 ( 2.5A);None","1.23A","3kcxA-3puaA:17.1","3kcxA-3puaA:23.13"],["3KCX_A_CQLA1_0","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","4c8d","LYSINE-SPECIFIC DEMETHYLASE 3B","Homo sapiens",5,"THR A1557;HIS A1560;ASP A1562;ILE A1683;HIS A1689","OGA A2722 (-3.3A); MN A2721 ( 3.3A); MN A2721 ( 3.0A);None; MN A2721 ( 3.2A)","0.50A","3kcxA-4c8dA:14.3","3kcxA-3puaA:23.13"],["3KCX_A_CQLA1_0","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","4qkf","ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB HOMOLOG 7, MITOCHONDRIAL","Homo sapiens",5,"LEU A 110;HIS A 121;ASP A 123;HIS A 177;ILE A 179","OGA A 301 ( 4.6A); MN A 300 ( 3.4A); MN A 300 (-2.9A); MN A 300 ( 3.5A);None","1.10A","3kcxA-4qkfA:8.9","3kcxA-4c8dA:19.64"],["3U9F_D_CLMD221_0","CHLORAMPHENICOL ACETYLTRANSFERASE","4eyu","LYSINE-SPECIFIC DEMETHYLASE 6B","Mus musculus",5,"SER A1398;PHE A1454;VAL A1462;ALA A1412;HIS A1390","OGA A1700 (-2.8A);None;None;None; NI A1701 ( 3.3A)","1.35A","3u9fD-4eyuA:undetectable;3u9fE-4eyuA:undetectable","3kcxA-4qkfA:22.80"],["3U9F_G_CLMG221_0","CHLORAMPHENICOL ACETYLTRANSFERASE","4eyu","LYSINE-SPECIFIC DEMETHYLASE 6B","Mus musculus",5,"SER A1398;PHE A1454;VAL A1462;ALA A1412;HIS A1390","OGA A1700 (-2.8A);None;None;None; NI A1701 ( 3.3A)","1.32A","3u9fG-4eyuA:undetectable;3u9fH-4eyuA:undetectable","3u9fD-4eyuA:16.46;3u9fE-4eyuA:16.46"],["3UJ7_B_SAMB302_1","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","2pxj","JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROTEIN 3A","Homo sapiens",4,"TYR A 141;SER A 288;ASP A  61;ILE A  62","None;OGA A5001 (-3.5A);None;None","1.34A","3uj7B-2pxjA:undetectable","3u9fG-4eyuA:16.46;3u9fH-4eyuA:16.46"],["4J6D_A_TESA503_1","CYTOCHROME P450 MONOOXYGENASE","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",5,"PHE A 250;GLN A 200;ALA A 279;ALA A 198;ALA A 281","None;None;OGA A 402 (-3.6A);OGA A 402 ( 4.2A);OGA A 402 ( 3.7A)","1.08A","4j6dA-5lunA:undetectable","3uj7B-2pxjA:23.25"],["4J6D_B_TESB502_1","CYTOCHROME P450 MONOOXYGENASE","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",5,"PHE A 250;GLN A 200;ALA A 279;ALA A 198;ALA A 281","None;None;OGA A 402 (-3.6A);OGA A 402 ( 4.2A);OGA A 402 ( 3.7A)","1.08A","4j6dB-5lunA:undetectable","4j6dA-5lunA:20.91"],["4JBT_A_ASDA501_1","CYTOCHROME P450 MONOOXYGENASE","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",5,"PHE A 250;GLN A 200;ALA A 279;ALA A 198;ALA A 281","None;None;OGA A 402 (-3.6A);OGA A 402 ( 4.2A);OGA A 402 ( 3.7A)","1.10A","4jbtA-5lunA:undetectable","4j6dB-5lunA:20.91"],["4KOT_A_CE3A205_1","UNCHARACTERIZED PROTEIN","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",5,"PHE A 283;ARG A 321;GLY A  77;TYR A 126;LEU A 173","ARG A 403 ( 4.2A);None;None;None;OGA A 402 (-4.5A)","1.50A","4kotA-5lunA:undetectable","4jbtA-5lunA:20.91"],["4KOW_A_CFXA204_1","UNCHARACTERIZED PROTEIN","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",5,"PHE A 283;ARG A 321;GLY A  77;TYR A 126;LEU A 173","ARG A 403 ( 4.2A);None;None;None;OGA A 402 (-4.5A)","1.50A","4kowA-5lunA:undetectable","4kotA-5lunA:20.29"],["4LRH_D_FOLD301_1","FOLATE RECEPTOR ALPHA","3avs","LYSINE-SPECIFIC DEMETHYLASE 6A","Homo sapiens",3,"HIS A1226;TRP A1194;SER A1154"," NI A1503 ( 3.4A);None;OGA A1501 (-2.7A)","1.17A","4lrhD-3avsA:undetectable","4kowA-5lunA:20.29"],["4LRH_D_FOLD301_1","FOLATE RECEPTOR ALPHA","4eyu","LYSINE-SPECIFIC DEMETHYLASE 6B","Mus musculus",3,"HIS A1470;TRP A1438;SER A1398"," NI A1701 ( 3.1A);None;OGA A1700 (-2.8A)","1.16A","4lrhD-4eyuA:undetectable","4lrhD-3avsA:17.40"],["4LTW_A_486A302_1","ANCESTRAL STEROID RECEPTOR 2","4qkf","ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB HOMOLOG 7, MITOCHONDRIAL","Homo sapiens",5,"LEU A 110;LEU A 145;ILE A 179;ILE A  70;ALA A  69","OGA A 301 ( 4.6A);None;None;None;None","1.09A","4ltwA-4qkfA:undetectable","4lrhD-4eyuA:18.11"],["4O8F_B_BRLB501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2pxj","JMJC DOMAIN-CONTAINING HISTONE DEMETHYLATION PROTEIN 3A","Homo sapiens",5,"SER A 196;LEU A  44;VAL A 260;PHE A 185;HIS A 188","OGA A5001 (-2.7A);None;None;OGA A5001 (-3.8A);FE2 A3001 ( 3.5A)","1.22A","4o8fB-2pxjA:undetectable","4ltwA-4qkfA:23.22"],["4QZT_A_RTLA201_0","RETINOL-BINDING PROTEIN 2","4bhi","GAMMA-BUTYROBETAINE DIOXYGENASE","Homo sapiens",5,"ILE A 358;TYR A 194;GLN A 215;LEU A 217;LEU A 362","None;RUJ A 401 (-4.3A); ZN A 402 ( 4.2A);None;OGA A 400 (-4.9A)","1.43A","4qztA-4bhiA:undetectable","4o8fB-2pxjA:21.35"],["4YHA_B_MZMB303_1","ALPHA-CARBONIC ANHYDRASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1416;HIS A1881;VAL A1395;VAL A1900;ALA A1379","OGA A2001 (-3.9A); FE A2003 ( 3.2A);OGA A2001 ( 4.9A);OGA A2001 ( 4.9A);OGA A2001 ( 4.4A)","1.36A","4yhaB-5deuA:undetectable","4qztA-4bhiA:17.53"],["4YHA_G_MZMG303_1","ALPHA-CARBONIC ANHYDRASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1416;HIS A1881;VAL A1395;VAL A1900;ALA A1379","OGA A2001 (-3.9A); FE A2003 ( 3.2A);OGA A2001 ( 4.9A);OGA A2001 ( 4.9A);OGA A2001 ( 4.4A)","1.49A","4yhaG-5deuA:undetectable","4yhaB-5deuA:18.87"],["5DV4_A_NMYA601_1","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE","6fqc","BIFUNCTIONAL ARGININE DEMETHYLASE AND LYSYL-HYDROXYLASE JMJD6","Homo sapiens",5,"TYR A 131;PRO A 171;ASP A 189;ASN A 287;HIS A 187","None;None; MN A 501 ( 2.6A);OGA A 506 ( 4.6A); MN A 501 ( 3.4A)","1.38A","5dv4A-6fqcA:undetectable","4yhaG-5deuA:18.87"],["5ECM_A_LEUA602_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","3pua","PHD FINGER PROTEIN 2","Homo sapiens",4,"THR A 246;ALA A 322;THR A 323;HIS A 249","OGA A 454 (-3.8A);None;OGA A 454 (-2.9A); NI A   2 ( 3.3A)","1.22A","5ecmA-3puaA:undetectable","5dv4A-6fqcA:12.70"],["5KC0_A_RBFA303_1","RIBOFLAVIN TRANSPORTER RIBU","4bhi","GAMMA-BUTYROBETAINE DIOXYGENASE","Homo sapiens",5,"GLU A 230;LEU A 199;ALA A 294;ASN A 292;PHE A 291","None;OGA A 400 (-4.8A);None;RUJ A 401 (-4.1A);None","1.43A","5kc0A-4bhiA:undetectable","5ecmA-3puaA:21.40"],["5TT3_E_EZLE303_1","ALPHA-CARBONIC ANHYDRASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1416;HIS A1881;VAL A1395;VAL A1900;ALA A1379","OGA A2001 (-3.9A); FE A2003 ( 3.2A);OGA A2001 ( 4.9A);OGA A2001 ( 4.9A);OGA A2001 ( 4.4A)","1.42A","5tt3E-5deuA:undetectable","5kc0A-4bhiA:19.01"],["5TT3_G_EZLG303_1","ALPHA-CARBONIC ANHYDRASE","5deu","METHYLCYTOSINE DIOXYGENASE TET2, CHIMERIC CONSTRUCT","Homo sapiens",5,"HIS A1416;HIS A1881;VAL A1395;VAL A1900;ALA A1379","OGA A2001 (-3.9A); FE A2003 ( 3.2A);OGA A2001 ( 4.9A);OGA A2001 ( 4.9A);OGA A2001 ( 4.4A)","1.46A","5tt3G-5deuA:undetectable","5tt3E-5deuA:18.87"],["5YF0_A_SAMA505_0","CARNOSINE N-METHYLTRANSFERASE","2rds","1-DEOXYPENTALENIC ACID 11-BETA HYDROXYLASE; FE(II)\/ALPHA-KETOGLUTARATE DEPENDENT HYDROXYLASE","Streptomyces avermitilis",5,"GLY A 164;GLY A 165;ASN A 231;SER A 242;TYR A   8","None;None;None;OGA A 268 ( 4.5A);None","1.24A","5yf0A-2rdsA:undetectable","5tt3G-5deuA:18.87"],["6DK1_C_GM4C301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5lun","2-OXOGLUTARATE-DEPENDENT ETHYLENE\/SUCCINATE-FORMING ENZYME","Pseudomonas savastanoi",5,"ALA A 281;TYR A 318;ASP A  91;GLU A  84;THR A  97","OGA A 402 ( 3.7A);None;ARG A 403 ( 4.7A);ARG A 403 (-3.5A);None","1.22A","6dk1C-5lunA:4.3","5yf0A-2rdsA:19.67"],["6HU9_S_PCFS603_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 8;CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL","3avs","LYSINE-SPECIFIC DEMETHYLASE 6A","Homo sapiens",4,"GLN A1133;GLY A1128;VAL A1268;SER A1154","None;None;None;OGA A1501 (-2.7A)","0.80A","6hu9S-3avsA:undetectable;6hu9q-3avsA:undetectable","6dk1C-5lunA:21.55"],["6HU9_S_PCFS603_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 8;CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL","4eyu","LYSINE-SPECIFIC DEMETHYLASE 6B","Mus musculus",4,"GLN A1377;GLY A1372;VAL A1512;SER A1398","None;None;None;OGA A1700 (-2.8A)","0.89A","6hu9S-4eyuA:undetectable;6hu9q-4eyuA:undetectable","6hu9S-3avsA:10.12;6hu9q-3avsA:12.99"],["6MA7_A_TPFA602_0","CYTOCHROME P450 3A4","4qkf","ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE ALKB HOMOLOG 7, MITOCHONDRIAL","Homo sapiens",4,"ARG A 191;ARG A 197;ALA A 114;ILE A 179","None;OGA A 301 (-3.0A);None;None","0.95A","6ma7A-4qkfA:undetectable","6hu9S-4eyuA:10.74;6hu9q-4eyuA:14.38"]]